Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

The rapid development of mRNA-based vaccines against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) led to the design of accelerated vaccination schedules that have been extremely effective in naive individuals. While a two-dose immunization regimen with the BNT162b2 vaccine has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozano-Ojalvo, Daniel, Camara, Carmen, Lopez-Granados, Eduardo, Nozal, Pilar, del Pino-Molina, Lucía, Bravo-Gallego, Luz Yadira, Paz-Artal, Estela, Pion, Marjorie, Correa-Rocha, Rafael, Ortiz, Alberto, Lopez-Hoyos, Marcos, Iribarren, Marta Erro, Portoles, Jose, Rojo-Portoles, Maria Pilar, Ojeda, Gloria, Cervera, Isabel, Gonzalez-Perez, Maria, Bodega-Mayor, Irene, Montes-Casado, Maria, Portoles, Pilar, Perez-Olmeda, Mayte, Oteo, Jesus, Sanchez-Tarjuelo, Rodrigo, Pothula, Venu, Schwarz, Megan, Brahmachary, Manisha, Tan, Anthony Tanoto, Le Bert, Nina, Berin, Cecilia, Bertoletti, Antonio, Guccione, Ernesto, Ochando, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332924/
https://www.ncbi.nlm.nih.gov/pubmed/34390647
http://dx.doi.org/10.1016/j.celrep.2021.109570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332924/
https://www.ncbi.nlm.nih.gov/pubmed/34390647
http://dx.doi.org/10.1016/j.celrep.2021.109570

Ejemplares similares